 |
 |
 |

|
Fibromyalgia |
Arthritis |
Migraine |

Chronic Pain |
|

Chronic
pain affects 1 out of 3 people in the United States. Back pain,
migraine headaches, fibromyalgia, and irritable bowel syndrome are
examples of common pain conditions; the focus of research studies
that assess the effectiveness of medication to alleviate pain or to
increase the function of the chronic pain sufferer. The goals of new
chronic pain treatments include decreasing daily pain, improving
sleep, and treating the depression and chronic fatigue that often
accompany chronic pain. Health education is a cornerstone of chronic
pain treatment.
|

|

 |

Fibromyalgia Pain Syndrome (FMS)
Fibromyalgia is a chronic syndrome with symptoms of widespread
pain, stiffness, fatigue and poor sleep. Fibromyalgia symptoms
of pain, chronic fatigue and insomnia affect 2% of adults in
the United States. Women experience fibromyalgia pain symptoms
50% more often than men. Traditional pain medications such as
nonsteroidal anti-inflammatory drugs (NSAIDS) have been
relatively ineffective in relieving the pain of fibromyalgia.
Clinical studies are ongoing that study the effectiveness of
potential new therapies in the treatment of fibromyalgia.
These new interventions focus on nerve conduction, rather than
muscle or joint function, as our understanding of fibromyalgia
moves from the prospective of a musculoskeletal disease to a
neuromuscular disease. Clinical studies evaluating
fibromyalgia treatment include medications to decrease the
patient’s suffering from pain, insomnia, depression and muscle
tenderness. With fibromyalgia may come symptoms of irritable
bowel, decreased mental clarity, and decreased libido.
|
|

 |

Arthritis
Clinical research for treatment of arthritis and joint pain sufferers has been
particularly eventful as new COX inhibitors have entered the
marketplace and then retreated as dangerous side effects limit
their usefulness. New drug trials are examining ways to reduce
the potential for gastrointestinal bleeding, a dangerous
complication of prolonged NSAID use in any pain condition.
|
|

 |

Chronic Low Back Pain
Most people suffer from low back pain at some time in their
lives. 90% of patients improve within 12 weeks. Ten per cent
of patients with low back pain do not improve in 12 weeks and
their pain becomes chronic. Chronic low back pain is difficult
to treat and is one of the most common contributors to lost
productivity in the United States. Doctors often treat
patients with chronic low back pain with medication for
osteoarthritis. Recent research shows that some patients with
chronic low back pain have central sensitization of their
pain. This central pain is often successfully treated with
antidepressant medication. Many doctors provide health
education regarding diet, exercise and wellness alternatives
for treatment of chronic low back pain. Research studies that
evaluate a medication’s effectiveness in relieving back and
joint pain are part of the options for pain sufferers.
|

 |

Migraine Headaches
New medications to treat migraine headaches have become available,
but research studies continue as new treatments focus on prevention
as well as shortening the duration and diminishing the intensity of
headache pain, nausea and vomiting. Migraine headaches are more
frequent in women, and may occur in cycles around the menses. Early
treatment and the avoidance of triggers are important strategies in
migraine symptom relief and warding off severe migraines.
|

 |

Meridien
Research offers the opportunity to participate in clinical trials and medical research for a number of important diseases
such as migraine headaches, arthritis, and fibromyalgia. With
research offices located in Tampa, St. Petersburg and Brooksville,
participants living in Florida can conveniently access
the latest advances in medicine. |
|
|
 |